WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004007539) HSP70 FROM ARTHROBACTER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/007539    International Application No.:    PCT/EP2003/007602
Publication Date: 22.01.2004 International Filing Date: 14.07.2003
Chapter 2 Demand Filed:    14.01.2004    
IPC:
A61K 39/02 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichtstrasse 35, CH-4056 Basel (CH) (AE, AG, AL, AM, AU, AZ, BA, BB, BE, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, FR, GB, GD, GE, GH, GR, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MC, MD, MK, MN, MX, NI, NL, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SE, SG, SI, SK, TJ, TM, TN, TR, TT, UA, UZ, VC, VN, YU, ZA, ZW only).
NOVARTIS PHARMA GMBH [AT/AT]; Brunner Strasse 59, A-1230 Vienna (AT) (AT only).
GRIFFITHS, Steven, Gareth [GB/CA]; (CA) (For US Only).
RITCHIE, Rachel, Jane [CA/CA]; (CA) (For US Only).
SIMARD, Nathalie, C. [CA/CA]; (CA) (For US Only)
Inventors: GRIFFITHS, Steven, Gareth; (CA).
RITCHIE, Rachel, Jane; (CA).
SIMARD, Nathalie, C.; (CA)
Agent: GRUBB, Philip; Novartis AG, Corporate Intellectual Property, CH-4002 Basel (CH)
Priority Data:
0216414.3 15.07.2002 GB
Title (EN) HSP70 FROM ARTHROBACTER
(FR) GENE HSP70 PROVENANT DU GENRE ARTHROBACTER
Abstract: front page image
(EN)The hsp70 gene from an Arthrobacter species has been isolated and sequenced. The encoded protein is believed to be highly immunogenic, especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens.
(FR)L'invention concerne le gène hsp70 provenant du genre Arthrobacter, isolé et séquencé. Il semble que la protéine codée soit hautement immunogène, notamment chez les poissons, et qu'elle soit utile comme adjuvant non spécifique, et comme vecteur adjuvant pour antigènes hétérologues.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MD, MK, MN, MX, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SE, SG, SK, TJ, TM, TN, TR, TT, UA, US, UZ, VC, VN, YU, ZA, ZW.
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR).
Publication Language: English (EN)
Filing Language: English (EN)